An oral protein cocktail therapeutic for C. difficile infection
H. Zhao, M. Dodds, A. Pollock, M. Gewe, A. Martinez, K. Keeney, B. Jester, M. Hutton, H. Tabakh, M. Zhang, M. Heinnickel, T. Paddock, S. Ertel, K. Aggarwal, C. Amendola, , Guzma
This paper describes an oral protein cocktail, LMN-201, for C. difficile infection, showing it achieves high cure rates and validates spirulina as a delivery platform.
bioRxiv · Dec 21, 2021 · PreprintBioengineering